Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children

S N Wong1, E C Yu, A S Lok

  • 1Department of Paediatrics, University of Hong Kong.

Insights

Interferon therapy offers a potential treatment for children with persistent nephrotic syndrome linked to chronic hepatitis B virus infection. While outcomes vary, it may induce remission or seroconversion in some cases.

Area of Science:

  • Pediatric Nephrology
  • Hepatology
  • Virology

Background:

  • Nephrotic syndrome in children can be associated with chronic hepatitis B virus (HBV) infection.
  • Chronic carriers of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) may develop glomerulonephritis.
  • Limited treatment options exist for persistent nephrotic syndrome secondary to HBV.

Observation:

  • Two pediatric patients with persistent nephrotic syndrome and chronic HBV carriage (HBsAg+, HBeAg+) were studied.
  • Renal biopsies revealed membranous glomerulonephritis, and liver biopsies showed chronic persistent hepatitis.
  • Both patients received interferon-alpha-2a treatment after prolonged nephrotic syndrome.

Findings:

  • Patient 1 achieved complete remission of nephrotic syndrome and hepatosplenomegaly, but remained positive for HBsAg, HBeAg, and HBV DNA.
  • Patient 2 experienced a transient clinical response and seroconverted from HBeAg positive to anti-HBe positive.
  • Treatment outcomes with interferon-alpha-2a were variable in these cases.

Implications:

  • Interferon therapy is a consideration for severe, persistent nephrotic states associated with HBV.
  • Further research is needed to optimize interferon treatment protocols for pediatric HBV-related glomerulonephritis.
  • This study highlights the complex interplay between HBV infection and renal pathology in children.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...